Danish pharma company restructures amid US and EU patent disputes
Gibson Dunn & Crutcher and Davis Polk & Wardwell have helped Danish drugs manufacturer Forward Pharma complete a corporate restructuring, which the company says should guard it against the outcome of a number of patent disputes in the US and Europe.
To read more
Subscribe to Global Restructuring Review
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Restructuring Review experts.